R Naumann

Summary

Country: Germany

Publications

  1. ncbi Pain perception in patients undergoing bone marrow puncture--a pilot study
    R Naumann
    Department of Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, Germany
    Percept Mot Skills 98:116-22. 2004
  2. ncbi Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
    R Naumann
    Department of Medicine I, University Hospital Carl Gustav Carus at the Dresden University of Technology, Fetscherstr 74, 01307 Dresden, Germany
    Br J Cancer 90:620-5. 2004
  3. ncbi Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma
    R Naumann
    Department of Internal Medicine I, University Hospital Carl Gustav Carus at the Dresden University of Technology, Fetscherstrasse 74, D 01307 Dresden, Germany
    Br J Haematol 115:793-800. 2001
  4. ncbi Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma
    M Hanel
    Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
    J Cancer Res Clin Oncol 127:387-95. 2001
  5. ncbi Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity
    R Naumann
    Department of Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany
    Br J Haematol 115:323-5. 2001
  6. ncbi Transverse leukonychia following chemotherapy in a patient with Hodgkin's disease
    R Naumann
    Department of Medicine I and Department of Dermatology, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
    Eur J Dermatol 10:392-4. 2000
  7. ncbi Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation
    C Schimmelpfennig
    Medizinische Klinik und Poliklinik I, , Fetscher Str. 74, 01307 Dresden, Germany
    Bone Marrow Transplant 27:753-5. 2001
  8. ncbi A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes
    U Oelschlaegel
    Medical Clinic and Policlinic I, University Hospital Dresden, Haus 66a, Fetscherstrasse 74, 01307 Dresden, Germany
    Clin Lab Haematol 23:81-90. 2001
  9. ncbi Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals
    B Mohr
    Medizinische Klinik und Poliklinik I, , Fetscherstrasse 74, 01307 Dresden, Germany
    Cancer Genet Cytogenet 127:111-7. 2001
  10. ncbi Primary renal non-Hodgkin's lymphoma - a difficult differential diagnosis
    J Gellrich
    Department of Urology, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
    Onkologie 25:273-7. 2002

Collaborators

Detail Information

Publications12

  1. ncbi Pain perception in patients undergoing bone marrow puncture--a pilot study
    R Naumann
    Department of Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, Germany
    Percept Mot Skills 98:116-22. 2004
    ..This finding must be considered when planning psychological interventions in this group of patients...
  2. ncbi Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
    R Naumann
    Department of Medicine I, University Hospital Carl Gustav Carus at the Dresden University of Technology, Fetscherstr 74, 01307 Dresden, Germany
    Br J Cancer 90:620-5. 2004
    ....
  3. ncbi Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma
    R Naumann
    Department of Internal Medicine I, University Hospital Carl Gustav Carus at the Dresden University of Technology, Fetscherstrasse 74, D 01307 Dresden, Germany
    Br J Haematol 115:793-800. 2001
    ..In conclusion, FDG-PET is a suitable non-invasive method with a high degree of accuracy in the prediction of early recurrence in lymphoma patients with CRu...
  4. ncbi Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma
    M Hanel
    Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
    J Cancer Res Clin Oncol 127:387-95. 2001
    ....
  5. ncbi Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity
    R Naumann
    Department of Medicine I, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany
    Br J Haematol 115:323-5. 2001
    ..Recognizing early signs of HMSN, such as areflexia and pes cavus deformity, can prevent severe neurotoxicity of polychemotherapy by avoiding vincristine...
  6. ncbi Transverse leukonychia following chemotherapy in a patient with Hodgkin's disease
    R Naumann
    Department of Medicine I and Department of Dermatology, University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany
    Eur J Dermatol 10:392-4. 2000
    ..We observed a 21-year-old female patient with Hodgkin's lymphoma, who developed transverse leukonychia of all fingernails associated with polychemotherapy...
  7. ncbi Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation
    C Schimmelpfennig
    Medizinische Klinik und Poliklinik I, , Fetscher Str. 74, 01307 Dresden, Germany
    Bone Marrow Transplant 27:753-5. 2001
    ....
  8. ncbi A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes
    U Oelschlaegel
    Medical Clinic and Policlinic I, University Hospital Dresden, Haus 66a, Fetscherstrasse 74, 01307 Dresden, Germany
    Clin Lab Haematol 23:81-90. 2001
    ..In conclusion, the combination of the test kits enables the differential diagnosis of PNH clones in a standardized, simple and rapid approach which may have therapeutic consequences...
  9. ncbi Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals
    B Mohr
    Medizinische Klinik und Poliklinik I, , Fetscherstrasse 74, 01307 Dresden, Germany
    Cancer Genet Cytogenet 127:111-7. 2001
    ..Due to these results we recommend that the initial diagnosis as well as the follow-up of patients with Ph+ leukemias should not be based on a single technique but should integrate results of cytogenetics and molecular biology...
  10. ncbi Primary renal non-Hodgkin's lymphoma - a difficult differential diagnosis
    J Gellrich
    Department of Urology, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
    Onkologie 25:273-7. 2002
    ..CONCLUSION: PRL represents a rare entity which must nevertheless be considered in cases of unusual renal masses or otherwise unexplained renal symptoms. If diagnosed early, cure is possible, and multimodal treatment should be considered...
  11. ncbi 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group
    M Sieber
    German Hodgkin s Lymphoma Study Group, Klinik fur Innere Medizin, University of Cologne, Germany
    J Clin Oncol 21:1734-9. 2003
    ....
  12. ncbi A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)
    V Ballova
    Department of Internal Medicine I, University Hospital of Cologne, Cologne and the German Hodgkin Lymphoma Study Group, Germany
    Ann Oncol 16:124-31. 2005
    ..Hodgkin-specific FFTF at 5 years was 55% after COPP-ABVD and 74% after BEACOPP (P=0.13). Thus, there are no differences in survival between these regimens in elderly patients...